Immunotoxicity of nitrobenzene in female B6C3F1 mice. 1994

L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
Department of Pharmacology, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298.

Nitrobenzene (NBZ) is primarily employed as an oxidizing agent in the synthesis of analine and benzene compounds. It produces myelotoxic effects and effects on erythrocytes in both animal models and man. Reported hepatosplenomegaly and effects on the bone marrow are indicators that NBZ may be immunotoxic. In these studies, female B6C3F1 mice were exposed to 30, 100 and 300 mg/kg of NBZ in corn oil by gavage for 14 consecutive days. To assess the immunotoxic potential of NBZ, body and organ weights were determined and selected immunologic and host resistance responses were studied. In these studies, the liver and spleen appeared to be the primary target organs. Both liver and spleen weights were dose dependently increased. Gross histopathologic examinations revealed significant changes in the spleen, consisting of severe congestion of the red pulp areas with erythrocytes and reticulocytes. Serum chemistry profiles showed increases in alanine aminotransferase and aspartate aminotransferase activities, indicating liver toxicity. Hematologic studies showed a decrease in erythrocyte number and a concomitant increase in mean corpuscular hemoglobin and mean corpuscular volume. A dose-dependent increase in peripheral reticulocytes was also seen. DNA synthesis was enhanced, as was the number of formed elements and the number of monocyte/granulocyte stem cells in the bone marrow of treated mice. IgM responses were decreased and the phagocytic activity of macrophages in the liver was dose dependently increased with a concomitant decrease in the activities in the spleen and lung. Other immunological parameters examined were unchanged. Host resistance to microbial or viral infection was not markedly altered by NBZ; however, there were trends towards increased susceptibility where T-cell function contributes to host defense. These data indicate that NBZ-induced hemolysis and liver injury are linked to the observed alterations in bone marrow activity.

UI MeSH Term Description Entries
D007239 Infections Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases. Infection,Infection and Infestation,Infections and Infestations,Infestation and Infection,Infestations and Infections
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009578 Nitrobenzenes BENZENE derivatives carrying nitro group substituents.
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random

Related Publications

L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
August 1997, Drug and chemical toxicology,
L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
November 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology,
L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
May 2001, Drug and chemical toxicology,
L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
January 2006, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering,
L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
September 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology,
L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
December 2020, Journal of immunotoxicology,
L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
May 1996, Toxicology,
L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
January 1994, Drug and chemical toxicology,
L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
January 1994, Drug and chemical toxicology,
L A Burns, and S G Bradley, and K L White, and J A McCay, and B A Fuchs, and M Stern, and R D Brown, and D L Musgrove, and M P Holsapple, and M I Luster
November 2023, Journal of applied toxicology : JAT,
Copied contents to your clipboard!